Interview Questions
Please let me know if I missed any, and general thoughts on the overall list. I'll try to get to as many as possible.
If anyone else is speaking with management, this is can be a good resource to find further ideas for your discussion. This is a great list, much appreciated and thanks to everyone who contributed. (feel free to add over the next couple hours)
[some may be duplicates, I'm going to go over the list more thoroughly very soon]
Daktari (#17289)
1) With the given extended timeline, will haptic feedback be incorporated?
2) Can they expand on which instrumentation is being added?
3) Why can't they show videos like they have done in the past?
4) Which hospitals did they get their feedback from?
And for you point; What was his opinion on the market reaction?
JMAC13 (#17326)
1) Haptic feedback? (Don't want an oversight) they have the time.
2) Q1 2015 Milestone MUST HIT (are we 100% on schedule? Will save shareholder value and stop a plummet to .50 PPS.
3) PR's And more visibility (via, videos etc. ).
jetuomi (#17307)
1) Are they confident the current prototype can do the single indication they set out to do, or is that being revised in the new schedule as well?
2) Will future indications beyond this current set require additional time or will they be like Intuitive, simply bolt-ons and software updates?
3) Not a question - remind them that higher stock prices allow for more warrants and higher likelihood of uplisting in US which brings more institutions than anything Bertner does on the side.
Noemotionseller (#17330)
1) if ISRG comes out and says they are FDA approved for single port XXXXXX procedure, will the board delay again to also achieve XXXXX FDA?
2)Does titan have plans to get FDA approval for YYYYY procedures that no one has yet (THORACIC, TRAUMA, TRANSLUMEN??)
3) Are they now comfortable and committed to on time (PLEASE GOD....AHEAD OF TIME) roll out??
4) Also, would they consider CUINN's proposal of getting paid in stock with a PPS limit set of 3-4??
Golf Pro (#17538)
"No one expected sport to stop at the Chole but speed to market and path of least resistance has been the recipe for success even ISRG initially had one indication. Why not prove to the market we have a viable machine and work on other indications concurrently rewarding shareholders and the company by sticking to the forecast and building confidence rather than losing many long time shareholders ."
Flenderson (#17443)
My question would simply be, with this recent milestone delay why should any investor consider investing in Titan Medical? Or maybe, why would you Mr. Rayman invest in Titan Medical right now?
Yes we understand the potential and value down the road. But, wouldn't my money serve me better elsewhere for the time being? I noticed there is a big gap between the 2nd and 3rd quarters of 2015. That potentially is 6 months of silence based off your history. Should I not put my hard earned money in a CD at that point earning .75%? At least I know it will be green at the end.
Chillout
1) Based on the recent decline in the stock, Is there a price point at which they would feel compelled to release updates on the progress they are making? They are after all a public company and should be looking after shareholder value.
2) Where are we with Institutional investments?
2.5)What is Sherry doing about this?
3) Are they planning another round of financing?
CUIN2 (#)
I've been invested in Titan almost since the beginning, but have been regretful of many of their moves. I was in when Craig Leon was CEO, and Amadeus was the future for us. Then we changed directions to SPORT with only 1 indication?
Please ask them why I should believe in them now, when twice they significantly changed the strategy? What can they tell me that will give me confidence that they know what they are doing, and that we have something that can be successful?
Cptjsd (#17450)
If you can I would bring up the topic of outstanding warrants that expire before or around the commercialization timeline of their new schedule. Are they expecting to have these warrants exercised and receive further proceeds from these warrants. A lot of posters on this board give the impression that management is not focused on the PPS but as a public company they will need PPS increases to get the additional funds from warrants as well as to get uplisted in the US(if they care) so institutions can buy in and Titan can get additional visibility. Also, ask them about the extended delay and try to get a feel on their new timeline and if it is conservative (even if they don't want you to post in the SA article), your opinion on what you think after speaking with them would help us investors.
Devicerep88 (#17488)
1) How much does the company value the patents they have and the development work done to date?
2) Have they received offers to be acquired and at what price?
3) Why are they going to GPO trade shows if they are delayed with a US launch?
4) I did see this question from someone else, think its a great question to ask: Why should anyone invest in Titan after going from a market cap of $230MM to $122MM in about 3-4 trading days?
5) Why so much investor silence when so much is going on behind the scenes?
6) Who are the largest shareholders of Titan? Are there any big name medical device companies with an active investment in Titan?
7) Do you have the patents and legal green light to go to market in the US?
8) Do you plan on selling SPORT for more now that you are delaying your launch so it can do more?
9) How much revenue will the average SPORT generate once installed from both a service contract and a disposable perspective per year?
10) Do you have the contractual obligation from Ximedica to continue development now that they have been acquired? What if Ximedica is unable or unwilling to complete the work?
11) What type of reaction did Titan expect from the announcement regarding the delay? Do they regret this decision now?
More questions...
1) Please add detail as to why the commercial release has been pushed back 5 quarters.
1b) What detail can you add to the new $17 million expenditure that reads “Units Built and ready for engineering verification”
2) If additional procedures were not added to the rollout would SPORT be ahead or behind of its key milestones as stated in the Jan 2014 MD&A .
2a) Please quantify how many months ahead or behind.
3) What are currently the most significant concerns from management?
4) What news can be released over the next 3-6 months to comfort your trusted shareholders?
4b)Can the company announce that tissue testing is complete (as per Development Milestone Nov 2014)
4c) What about deign freeze?
5) Are there any plans ahead for a three arm version of SPORT?
6) How is Shelly Bertner’s performance assessed?
1) Cash flow and profitability of the units, disposables, warranty profitability at launch, but also further out. Looking at %’s and industry averages might be the only avenue in the end as
2) Potential sales in Europe and the US. Estimates for Low, medium and high 6 months, 1 year out, 2 years out and 3 years? Looking to see how fast unit sales can ramp up once approvals have been met.
3) How will the Ximedica’s merger with SV Life Sciences impact on going SPORT development?
4) What is the estimated price and warranty costs the SPORT now going to be?
5) How many and what kind of disposables will be used if all of the procedures are approved?
6) Do you have a current supplier for disposables?
7) What has the feedback been from the medical community?
8) What do you see as the areas needing the greatest attention to get the product launched?
9) Is there any situation where the SPORT gets to market before Q4 2016?
10) When will cash reserves be used up based on burn rates to expand SPORT’s capabilities?
11) What are the technological challenges that SPORT is facing?
12) Are the FDA and CE certifications processes tightening up?
